Results
1 -
10 of
10Calcium Channel Blockers, Adverse Cutaneous Drug Reactions to Cardiovascular Drugs Contribution of aranidipine metabolites with slow binding kinetics to the vasodilating activity of aranidipine, Naunyn-Schmiedeberg's Archives of Pharmacology Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drugu2013drug interactions, European Journal of Clinical Pharmacology Loprinone and aranidipine gain first approvals, Inpharma Weekly In brief u2026, Inpharma Weekly News in briefu2026, Inpharma Weekly Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances [Online], Thieme: Stuttgart, (2003)..
Aranidipine, Pharmaceutical Substances